Biogen (BIIB) Net Margin (2009 - 2026)
Biogen (BIIB) reported Net Margin of 3.56% for Q2 2026, down 20.43 percentage points from 24.00% a year earlier and down 9.33 percentage points from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Net Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Biogen's Net Margin came in at 8.32%, down 6.99 percentage points year-over-year; for FY2025, it was 13.07%, down 3.80 percentage points from FY2024.
- Net Margin has a five-year change of -16.68 percentage points (FY2020 to FY2025).
- By year, Net Margin came in at 16.87% in FY2024 (+5.06 pp), 11.81% in FY2023 (-18.14 pp), 29.95% in FY2022 (+15.78 pp) and 14.17% in FY2021 (-15.59 pp).
- Five-year quarterly Net Margin spans a low of -2.69% in Q3 2023 and a high of 45.23% in Q3 2022.
- Year over year, Net Margin gained in five of the last eight quarters, with an average year-over-year change of -1.99 percentage points.
- The high point for year-over-year Net Margin in five years was Q3 2022 (a gain of 33.39 percentage points); the low point was Q3 2023 (a drop of 47.93 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 12.89% (Q1 2026), -2.15% (Q4 2025) and 18.40% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | -1.65% |
| 10 | Biogen | 36.75 Bn | 23.40 Bn | 1.96 Bn | 3.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.56% |
| Mar 31, 2026 | 12.89% |
| Dec 31, 2025 | -2.15% |
| Sep 30, 2025 | 18.40% |
| Jun 30, 2025 | 24.00% |
| Mar 31, 2025 | 9.89% |
| Dec 31, 2024 | 10.86% |
| Sep 30, 2024 | 15.76% |
| Jun 30, 2024 | 23.68% |
| Mar 31, 2024 | 17.18% |
| Dec 31, 2023 | 10.46% |
| Sep 30, 2023 | -2.69% |
| Jun 30, 2023 | 24.09% |
| Mar 31, 2023 | 15.75% |
| Dec 31, 2022 | 21.64% |
| Sep 30, 2022 | 45.23% |
| Jun 30, 2022 | 40.86% |
| Mar 31, 2022 | 12.00% |
| Dec 31, 2021 | 13.47% |
| Sep 30, 2021 | 11.85% |
API Access
Biogen Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();